On the public citation graph
Biological role of miR-204 and miR-211 in melanoma
0 signed · 27 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.ccr.2013.02.003openalex-snapshot
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
inferredcites →https://doi.org/10.1038/ncomms14343openalex-snapshot
Microenvironment-derived factors driving metastatic plasticity in melanoma
inferredcites →https://doi.org/10.1111/pcmr.12379openalex-snapshot
miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
inferredcites →https://doi.org/10.1158/0008-5472.can-17-1318openalex-snapshot
miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma
inferredcites →https://doi.org/10.1186/s12943-018-0819-8openalex-snapshot
Loss of miR-204 expression is a key event in melanoma
inferredcites →https://doi.org/10.18632/oncotarget.10669openalex-snapshot
miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
inferredcites →https://doi.org/10.18632/oncotarget.15915openalex-snapshot
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1007/s00210-024-03366-3openalex-snapshot
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.jid.2019.06.126openalex-snapshot
MicroRNA Ratios Distinguish Melanomas from Nevi
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2022.108301openalex-snapshot
Targeting the Epigenome in Malignant Melanoma: Facts, Challenges and Therapeutic Promises
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154991openalex-snapshot
MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting
inferred← citeshttps://doi.org/10.1038/s41419-019-2090-3openalex-snapshot
Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis
inferred← citeshttps://doi.org/10.1111/jcmm.14881openalex-snapshot
Long non‐coding RNA F11‐AS1 inhibits HBV‐related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA‐211‐5p
inferred← citeshttps://doi.org/10.1155/tbj/2122220openalex-snapshot
Lentinula edodes Cultured Extract Intake at Puberty Mitigates Inflammatory Signals at the Mammary Glands by the Involvement of Epigenetic Mechanisms in BALB/c Mice
inferred← citeshttps://doi.org/10.1186/s12935-022-02738-0openalex-snapshot
Current understanding of epigenetics role in melanoma treatment and resistance
inferred← citeshttps://doi.org/10.1186/s12943-026-02603-yopenalex-snapshot
miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma
inferred← citeshttps://doi.org/10.1186/s43556-026-00425-4openalex-snapshot
BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations
inferred← citeshttps://doi.org/10.1242/bio.053785openalex-snapshot
Inducible modulation of miR-204 levels in a zebrafish melanoma model
inferred← citeshttps://doi.org/10.14302/issn.2572-3030.jcgb-24-4970openalex-snapshot
Dynamic MicroRNA-Expression In Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
inferred← citeshttps://doi.org/10.18632/oncoscience.473openalex-snapshot
Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018)
inferred← citeshttps://doi.org/10.3390/biomedicines12081851openalex-snapshot
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
inferred← citeshttps://doi.org/10.3390/cancers12113378openalex-snapshot
The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy
inferred← citeshttps://doi.org/10.3390/cancers14235858openalex-snapshot
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies
inferred← citeshttps://doi.org/10.3390/cancers15030894openalex-snapshot
A Network of MicroRNAs and mRNAs Involved in Melanosome Maturation and Trafficking Defines the Lower Response of Pigmentable Melanoma Cells to Targeted Therapy
inferred← citeshttps://doi.org/10.3390/ijms21030878openalex-snapshot
The miRNAs Role in Melanoma and in Its Resistance to Therapy
inferred← citeshttps://doi.org/10.3390/ijms242115881openalex-snapshot
Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.